Skip to main content
Advances in Nutrition logoLink to Advances in Nutrition
. 2013 Sep 5;4(5):506–517. doi: 10.3945/an.113.004341

Mineral Malnutrition Following Bariatric Surgery1,2

Nana Gletsu-Miller 3,*, Breanne N Wright 3
PMCID: PMC3771134  PMID: 24038242

Abstract

Moderate/severe obesity is on the rise in the United States. Weight management includes bariatric surgery, which is effective and can alleviate morbidity and mortality from obesity-associated diseases. However, many individuals are dealing with nutritional complications. Risk factors include: 1) preoperative malnutrition (e.g., vitamin D, iron); 2) decreased food intake (due to reduced hunger and increased satiety, food intolerances, frequent vomiting); 3) inadequate nutrient supplementation (due to poor compliance with multivitamin/multimineral regimen, insufficient amounts of vitamins and/or minerals in supplements); 4) nutrient malabsorption; and 5) inadequate nutritional support (due to lack of follow-up, insufficient monitoring, difficulty in recognizing symptoms of deficiency). For some nutrients (e.g., protein, vitamin B-12, vitamin D), malnutrition issues are reasonably addressed through patient education, routine monitoring, and effective treatment strategies. However, there is little attention paid to other nutrients (e.g., zinc, copper), which if left untreated may have devastating consequences (e.g., hair loss, poor immunity, anemia, defects in neuro-muscular function). This review focuses on malnutrition in essential minerals, including calcium (and vitamin D), iron, zinc, and copper, which commonly occur following popular bariatric procedures. There will be emphasis on the complexities, including confounding factors, related to screening, recognition of symptoms, and, when available, current recommendations for treatment. There is an exceptionally high risk of malnutrition in adolescents and pregnant women and their fetuses, who may be vulnerable to problems in growth and development. More research is required to inform evidence-based recommendations for improving nutritional status following bariatric surgery and optimizing weight loss, metabolic, and nutritional outcomes.

Introduction

Popularity and Benefits of Bariatric Surgery

Weight loss through bariatric surgery is a popular treatment for moderate (BMI ≥35 kg/m2) and severe (BMI ≥40 kg/m2) obesity across most higher income countries and in 2011, >340,000 procedures were performed worldwide (1). In the United States, a leading country for bariatric surgery, there were ~160,000 bariatric procedures performed in 2010 (2). Bariatric surgery was developed in the 1960s and 1970s (3, 4), but its popularity began to increase in 1990 due to the dramatic rise in severe obesity (5, 6), improved safety of the operations (7), and a consensus statement by the NIH, which offered endorsement and guidance (8). Since 1990, United States data from the Nationwide Inpatient Sample and the American Society for Metabolic and Bariatric Surgery estimate that a total of 1,426,268 persons have undergone bariatric surgery (1, 912). The burden of severe obesity and comorbid cardio-metabolic disease, including type 2 diabetes (T2DM)4, atherosclerosis and cancer, is lifted from most of these individuals (1317). Moreover, decreased prevalence of morbidity, including athropathy, depression, poor quality of life (1820), and mortality (2124), following bariatric surgery is well documented.

Drawbacks of Bariatric Surgery: Nutritional Complications

Eligibility for bariatric surgery is described by a 1991 NIH consensus statement and includes individuals who have a BMI ≥40 kg/m2 or a BMI ≥35 kg/m2 and suffer from comorbid disease (8). In 2010, the US FDA expanded the criteria for eligibility by approving the use of a device used in the adjustable banding surgery (described below) for individuals who have a BMI ≥30 and have T2DM or other comorbidities (25). Despite the demonstrated benefits of bariatric surgery, it remains underutilized by eligible patients [∼1% have undergone surgery (2)] due to lack of accessibility (26), high costs and questionable cost-effectiveness (27, 28), and adverse outcomes that limit acceptability among patients, doctors, and third-party payers. The major adverse events relate to the complications of gastrointestinal surgery that typically occur within 30 d of the procedure and include wound infection, deep-vein thrombosis, small bowel obstructions, abdominal leaks, and death. Severely obese individuals undergoing major elective surgery are at a high risk for complications due to preexisting medical conditions (29); however, due to advances in laparoscopy, which is less invasive and traumatic, the operative mortality and morbidity has reduced to 0.1–0.3 and 4.5%, respectively, in recent years (7, 30). Despite improvement in perioperative safety, longer term complications are an important issue for patients undergoing bariatric surgery. These complications can be subdivided into those that are general or gastrointestinal surgery related (e.g., hernia, bowel obstruction, cholecystitis, slippage of gastric band/pouch dilation, ulcer, nausea, vomiting, diarrhea) (30), nutritional (hypoglycemia, loss of lean body mass, weight regain, vitamin and mineral deficiencies) (31, 32), or other (e.g., psychosocial issues, neisidioblastosis hyperinsulinemia, bacterial overgrowth) (24, 33, 34). The frequency of long-term complications following bariatric surgery is difficult to ascertain, because this has been mostly determined through retrospectively obtained data with poor patient follow-up and the various complications are specific to the type of surgery performed (14, 35). However, as evidenced by a growing body of case reports, retrospective studies, and a few prospective studies, poor nutritional outcomes are relatively common after surgery and prevalence of upwards of 82% has been reported (3638). Some nutritional complications are well known to the surgeons and other key practitioners (dietitians, primary care doctors, and endocrinologists) who provide postoperative support as well as to the patients themselves; these include malnutrition in protein, vitamin B-12, vitamin D, calcium, and iron. Thus, most clinical practices provide adequate patient counseling for prevention and routinely monitor patients for deficiency. However, for many other nutrients, including B vitamins (thiamine, pyridoxal phosphate, folate), fat-soluble vitamins (A, K), essential fatty acids, and minerals (zinc, copper), awareness of risk of deficiency by patients and providers is low and prophylactic protocols and monitoring are insufficient, leading to debilitating consequences including long-term disability (39). Moreover, as acknowledged by consensus guidelines from experts within the American Society for Metabolic and Bariatric Surgery, The Obesity Society and the American Association of Clinical Endocrinologists, there is need for more and better quality evidence behind recommendations for the prevention and treatment for malnutrition after bariatric surgery (35, 40).

The issues of nutritional deficiency following bariatric surgery were recently comprehensively reviewed (32, 35). However, this present review will focus on the problem of essential mineral deficiencies following specific surgery procedures, especially highlighting the complexities involved in monitoring and risk factors, as well as protocols for prevention and treatment. The issues in recognizing nutritional complications using clinical signs and symptoms as well as sensitive biomarkers will be discussed. We discuss the confounding issues related to symptoms and biomarkers of deficiency, including the masking of deficiency by other nutrients and by inflammation. Information is provided regarding strategies for prophylactic supplementation and interactions between nutrients that affect absorption and bioavailability. Finally, we discuss concerns of mineral malnutrition following bariatric surgery in special populations, namely adolescents and pregnant women.

Information in this review included published original articles and review papers that were collected using PubMed searches containing the subject headings bariatric surgery (gastric bypass surgery, adjustable gastric banding (AGB), sleeve gastrectomy (SG), bioliopancreatic diversion) and nutritional deficiencies (malnutrition, micronutrients, nutritional status) published between 1990 and May 2013. The impact of bariatric surgery on magnesium, phosphorus, electrolytes (e.g., potassium, sodium, chloride), and trace elements (e.g., selenium, iodine) is important, but the data were not sufficiently robust to be discussed in the review.

Current Status of Knowledge

Types of Bariatric Surgery Procedures

Bariatric surgeries are defined as procedures that alter the gastrointestinal tract to reduce caloric intake or absorption and can be classified by the mechanism of action for promoting weight loss as restrictive or malabsorptive. Restrictive procedures reduce the volume or capacity of the stomach and thereby limit caloric intake by promoting early satiety. Malabsorptive procedures reduce the amount of calories absorbed by altering the flow of food to limit contact with pancreatic secretions and bile acids and/or bypass the absorptive regions of the duodenum and proximal jejunum. Surgical alteration of the gastrointestine to restrict energy intake or promote malabsorption of macronutrients is achieved but with varying effectiveness and durability for sustained weight loss, as well as resulting nutritional side effects, depending on the extent of manipulation of the gastrointestinal system. The common bariatric surgery procedures are described herein along with features that may impair nutritional status.

The roux-en-y gastric bypass (RYGB) is the most popular surgical procedure in the United States at 47% of annual cases in 2011 (1). RYGB has a dual restrictive and malabsorptive mode of action as the stomach is reduced to a volume of 20–30 mL and stomach contents are rerouted to the distal jejunum via an anastomosis connection (Fig. 1) (41). The physiological mechanisms of RYGB for promoting weight loss are under intense investigation given the acute resolution of T2DM following surgery (42, 43), and potential mechanisms include caloric restriction and alterations in secretion of incretins, satiety gastrointestinal hormones, and bile acids and in the microbiome of the gut (44). Although malabsorption of proteins and fats occurs after RYGB, restricted dietary intake plays a much larger role in the reduction of energy intake (45), and following RYGB, patients dramatically reduce caloric intake to ∼1000 kcal/d (46, 47). Studies have shown decreased appetite and increased post-meal satiety following RYGB, likely due to decreases in ghrelin, an orexigenic hormone, and increases in glucagon-like peptide 1 and polypeptide YY, which are satiety hormones (4850). However, malabsorption may indirectly contribute to the reduction in dietary intake observed after RYGB. In the remnant stomach pouch, the reduced availability of stomach secretions of pepsin, rennin, and hydrochloric acid leads to a decreased capacity for digestion (51). Also, the shunting of undigested food directly to the lower gut, particularly if high in simple carbohydrates or fat, can produce an osmotic imbalance that triggers severe gastrointestinal symptoms such as bloating, nausea, vomiting, flatulence, and diarrhea, known as dumping syndrome (52). The uncomfortable gastrointestinal side-effects of mal-digestion and -absorption may cause patients to develop food intolerances and avoid nutrient-dense foods such as meat, milk, and high-fiber foods (53, 54). The processes of micronutrient absorption can be impaired following RYGB, because bioavailability requires digestive juices and acids in the stomach and small intestine and because absorption occurs primarily in the duodenum. Taken together, there are various reasons why RYGB can affect the status of macro- and micronutrients, including malabsorption, reduced dietary intake, and avoidance of nutrient-dense foods.

FIGURE 1.

FIGURE 1

Graphic depiction of bariatric surgery types.

The AGB procedure has decreased in popularity in recent years (from 44% in 2008 to 27% in 2011) (1). AGB restricts intake of food as a band is placed around the proximal stomach, encompassing the upper portion of the fundus and creating a temporary holding pouch of 30 mL; when food is ingested, the pouch expands and creates intraluminal pressure and satiety signals are triggered (Fig. 1) (55). An important feature of this surgery is that the surgeon, or an appropriate surrogate, is able to periodically tighten the band around the stomach so that the feeling of fullness is maintained; without this adjustment, the surgery is ineffective for weight loss (35, 56, 57). Nutritional complications related to AGB occur if the flow of food is obstructed by the narrowness of the band, which causes reflux, nausea, and/or vomiting. For this reason, patients tolerate softer foods compared with foods with a courser texture, leading to an avoidance of red meats and fibrous fruits and vegetables (54, 58, 59). A large study of patients who underwent AGB demonstrated that two-thirds experience an inability to eat certain foods and one-third reported regurgitation several times per week (58). Persistent vomiting following AGB has been shown to be a major cause of undernutrition following AGB (60).

The SG is an emerging restrictive procedure that is growing in popularity, reaching 19% in 2011 (1). The larger curvature of the stomach is dissected, leaving a narrow vertical tube that can hold a volume of 150 mL, thus similar to AGB, early satiety is achieved following a small meal (Fig. 1) (61). Increased satiety may also occur through mechanisms similar to those following RYGB, because the appetitive hormone ghrelin is decreased (62, 63) and the satiety hormone PYY is increased following SG (61). Moreover, a decrease in gastric emptying and small bowel transit time has been demonstrated after SG, which would limit the digestion and bioavailability of some nutrients (64). Indeed, poor diet quality is an expected outcome following SG, because patients experience difficulties with eating certain foods, as has been observed following RYGB (54).

The biliopancreatic diversion (BPD) and the more recent version, the BPD with duodenal switch, are primarily malabsorptive surgeries that are highly effective for weight loss but associated with nutritional complications that are difficult to treat (65). The popularity of this surgery is low in the United States (0.8% in 2011) and other countries, but historical cases exist (1). In the operation, the stomach is resected as is done for the SG (Fig. 1). In fact, SG is derived from the BPD but without alteration of the intestine (66). Immediately following exit from the stomach, the food chyme is diverted and then rejoined with biliary and pancreatic juices in a common channel that begins at the ileum. Thus, the nutritional consequences of BPD are similar to those encountered following RYGB but are more severe (6769) due to greater malabsorption, particularly of fat and fat-soluble vitamins (70).

Other Factors That Promote Poor Nutritional Status Following Bariatric Surgery

Candidates for bariatric surgery are often malnourished despite an overconsumption of calories, and obesity is a known risk factor for nutrient deficiency (71). Mechanisms besides poor dietary intake explain the association between obesity and poor nutritional status. The bioavailability of vitamin D is reduced in the obese state, because vitamin D is sequestered in adipose tissue (72, 73). Inflammation associated with obesity induces the production of hepcidin, an acute-phase protein made in the liver, which blocks iron absorption in the intestine (74). Also in obesity, hyperinsulinemia is associated with excessive urinary excretion of zinc, thus lowering plasma zinc concentrations (75). Assessment of nutritional status of severely obese patients before bariatric surgery has revealed varying rates of deficiencies, which is complicated by the lack of standardization of analytical tests and different referent ranges that were used. Typically vitamin D deficiency is high [ranging from 23 to 83%, using the cutoff of 50 nmol/L (76)] (7783). Deficiencies in vitamin B-12, iron, and zinc are not uncommon, ranging from 2 to 18% for vitamin B-12, 1 to 18% for iron, and 12 to 32% for zinc (77, 7981, 8488). Thus, preexisting nutritional deficiency may put patients undergoing bariatric surgery at risk for further nutritional complications. Although patients lose weight after bariatric surgery, many patients experience inadequate weight loss or weight regain (89, 90), so obesity-induced inflammation may still be an issue following surgery. Following bariatric surgery, expert recommendations are for a life-long regimen of daily micronutrient supplementation (35). However, compliance with this recommendation is mixed (59, 69, 91), because some patients: 1) do not recognize the need; 2) cannot bear the costs; or 3) are misled or confused by the large variety of commercial supplements, some of which are incomplete in specific vitamins or minerals (81, 85). Moreover, many patients do not undergo routine monitoring for deficiencies and thus the effectiveness of prophylactic supplementation is not clear (35). Thus, although surgery-induced dietary restriction or malabsorption is the major factor leading to malnutrition in the bariatric surgery patient, several nonsurgical factors can further exacerbate the issue.

Malnutrition in Calcium and Vitamin D

Calcium is an essential macromineral, making up to 2% of the human body, and functions in cell signaling and the mineralization of bone and teeth (92). Vitamin D is important for calcium homeostasis by regulating the absorption of calcium in the small intestine (93, 94). In addition to calcium metabolism, vitamin D has been implicated in the regulation of insulin action, immune function, and cell proliferation (95). Although blood concentration of calcium is often used as a marker of calcium status, this is not a good indicator because blood concentrations are tightly regulated (92). Bone represents a storage reservoir of calcium; thus, bone density, measured by dual X-ray absorptiometry, is better for assessment of calcium status and reference ranges for normal healthy individuals have been established using bone mineral density Z-scores (96). The impact of bariatric surgery on calcium and vitamin D is complicated, with surgery-induced changes in body weight, dietary intake, and gut absorption as influential factors. Compared with individuals of normal weight, obese individuals have higher bone density due to the positive effect of weight bearing on bone mineral accretion (97). Weight loss is known to reduce bone density, but this may not produce negative effects, because bone density may remain within the normal range (98100). With regards to absorption of calcium and other divalent metals (iron, copper, zinc) in the gastrointestine, acidic conditions are required for solubilization and transporters are most prevalent in the duodenum; therefore, decreased calcium absorption has been demonstrated after RYGB (100). Because it is fat soluble, vitamin D absorption may be decreased as well, although this has not yet been shown. However, a positive effect of surgery may be the decreased amount of body fat available for sequestration of vitamin D or a potential for release of vitamin D from fat stores during weight loss in the immediate period following surgery (101). Nevertheless, findings related to vitamin D status following bariatric surgery, measured by blood concentrations of 25-hydroxyvitamin D, have been conflicting, with decreases following BPD with duodenal switch (69) and RYGB (101) but an increase (102) or no change (72, 82) reported in other studies. The inconsistency in findings may relate to the large variation in supplementation of calcium and vitamin D reported in studies of bariatric surgery patients, ranging from doses close to the recommended dietary allowance to high-dose vitamin D supplementation (103105). Despite the equivocal findings for vitamin D, several studies have shown that bone mineral density decreases following restrictive (106) and malabsorptive (107109) surgeries due to weight loss and secondary hyperparathyroidism. However, a 3-y study of women undergoing RYGB demonstrated that although bone loss occurred, bone mineral density remained in the normal range and the risk of osteoporosis was low (109). Some studies have demonstrated that calcium and vitamin D supplementation may attenuate the risk of bone loss following bariatric surgery (110, 111) and expert recommendations are for daily supplementation of 1200–1500 mg calcium and at least 3000 international units of vitamin D (35) (Table 1). More research is needed to determine the optimum dosages for prophylactic supplementation to avoid adverse outcomes related to bone as well as nonosseous effects of calcium and vitamin D. It is also important to determine the longer term effects of bariatric surgery on calcium and vitamin D status, as well as bone mineral density, in growing adolescents.

TABLE 1.

Summary: risk factors, symptoms, indicators, and treatment of mineral deficiencies following bariatric surgery1

Mineral Risk factors Signs and symptoms Biochemical indicators Suggested treatment
Calcium Preexisting or current deficiency in vitamin D, RYGB, BPD-DS, SG, AGB, insufficient supplementation with calcium and/or vitamin D Low bone density, osteoporosis, muscle contractions, pain, spasms, paresthesias Bone densitometry using dual X-ray absorptiometry and referent Z-scores for age, parathyroid hormone, 25-hydroxyvitamin D for vitamin D status, plasma calcium is a poor indicator Oral supplementation of 1200–1500 mg calcium and at least 3000 IU vitamin D, high-dose vitamin D supplementation (50,000 IU/wk)
Iron Preexisting deficiency, menstruation (especially if excessive), BPD-DS, RYGB, SG, gastrointestinal bleeding, insufficient supplementation with iron, avoidance of meat, copper deficiency Fatigue, impaired work performance and productivity, anemia, inability to regulate body temperature, increased desire to eat ice and non-food items, white finger-nail beds Serum/plasma transferrin receptor and total iron binding capacity, serum/plasma iron is a poor indicator, serum/plasma ferritin may be elevated in inflammation, also screen for deficiency in vitamins B-6, B-12, folate, protein, copper, selenium, and zinc, and C-reactive protein (to assess inflammatory status) Oral ferrous sulfate, fumerate, or gluconate to provide 150–200 mg elemental iron daily, vitamin C, i.v. iron infusion, if severe
Zinc Preexisting deficiency, BPD-DS, RYGB, SG, avoidance of meat, high use of antacids Poor wound healing; dermatitis, blunting of taste sense, hair loss, impaired immunity Serum/plasma zinc (care must be taken to avoid contamination), inflammation can decrease zinc concentrations (also measure C-reactive protein) Oral zinc gluconate, sulfate, or acetate to provide 8–15 mg elemental zinc, 1 mg copper should be given for each 8–15 mg of zinc received
Copper BPD-DS, RYGB, SG, high use of antacids, high use of zinc supplementation or zinc lozenges Anemia, leukopenia, unsteady gait, numbness and tingling in hands and feet, painful paresthesias, poor wound healing, paralysis Serum/plasma copper (care must be taken to avoid contamination, serum/plasma ceruloplasmin, both copper and ceruloplasmin are elevated in inflammation (also measure C-reactive protein) Oral copper gluconate, oxide, or sulfate to provide 2–8 mg elemental copper, i.v. copper if severe
1

AGB, adjustable gastric banding; BPD-DS, biliopancreatic diversion with duodenal switch; RYGB, roux-en-y gastric bypass; SG, sleeve gastrectomy.

Malnutrition in Iron

Iron is an essential micromineral in the human body (at 0.005% by weight) and functions in heme and nonheme proteins involved in oxygen and electron transport. Iron deficiency is highly prevalent in developing countries but is also common in industrialized countries, especially in women of childbearing age (up to 16%) (112). Obesity increases the risk of iron deficiency, which may be explained by obesity-associated, low-grade inflammation and the induction of hepcidin, which blocks iron absorption proteins (74). Iron deficiency is therefore prevalent before surgery and is exacerbated following malabsorptive and restrictive procedures. In a recent retrospective analysis, the medical insurance claims of a large population of RYGB patients (17,930 cases) who had undergone nutritional testing for iron deficiency were obtained up to 36 mo following surgery (113). Although the rate of preoperative testing and postoperative follow-up was low (21, 53, 39, and 31% at baseline, and at 12, 24, and 36 mo following RYGB, respectively), iron deficiency increased from 5 to 22%. A strength of this study was the large sample size; a limitation was that the measures used to define iron deficiency were not specified and may have included serum iron, which is not sensitive, or serum ferritin, which can be elevated during inflammation, a common feature of obesity. However, the findings of this study are consistent with others that show exacerbation of iron deficiency when followed from before surgery and up to 60 mo following RYGB, where rates of deficiency between 10 and 45% were reported (77, 80, 81, 86, 87, 114, 115). Although restrictive procedures, including the SG, are thought to induce less malabsorption compared with the RYGB, a similar worsening of iron status and increased prevalence of deficiency (18–24%) following SG surgery has been reported (80, 81, 113). However, not all studies have shown a deterioration of iron status following SG surgery (77). Iron deficiency can occur without symptoms; however, symptomatic iron deficiency including anemia and feeling fatigue, cold, and a desire to eat ice are commonly reported following bariatric surgery (61, 114, 116, 117).

The complication of iron deficiency post bariatric surgery is difficult to diagnose and treat due to its multifactorial etiology and because its signs and symptoms, such as anemia, are shared with other nutrient deficiencies (114). Because of iron loss through menses, premenopausal women who have bariatric surgery are at increased risk for iron deficiency. Dietary intake of iron following surgery was reported to be lower than the recommended amount (81), possibly because patients avoid red meat, a good source of highly bioavailable heme iron (53). Using stable isotopes, it was demonstrated that absorption of heme and nonheme iron was shown to be reduced following RYGB and SG (118, 119), probably due to decreased acidity of the stomach pouch and bypass of the absorptive regions in the intestine. Also important is that iron absorption and metabolism are affected by the availability or status of other nutrients, including zinc, vitamin C, and copper. Excess dietary intake of zinc can compete with iron for absorption (120, 121), dietary vitamin C enhances the absorption of nonheme iron (122), and copper is needed for ceruloplasmin, which catalyzes the conversion of Fe2+ to Fe+++ so that it can be transported by transferrin into circulation (123, 124). Regarding diagnosis, total iron-binding capacity or serum transferrin receptor are better measures of iron deficiency compared with serum iron or ferritin; the latter can be elevated in the inflammatory condition of obesity (125). As suggested by recent guidelines, for the correct interpretation of anemia following bariatric surgery, a comprehensive nutritional assessment of iron as well as vitamins B-6 and B-12, folate, copper, selenium, and zinc is warranted, because anemia can result from each of these nutrients (35) (Table 1). The interrelatedness of iron and other nutrients, especially copper, must be considered during treatment using iron oral supplementation, particularly if symptoms persist. Some studies have shown that supplementation with i.v. iron has been shown to be successful (80, 111), but this needs to be done with caution to prevent iron overload and in a hospital setting (126).

Malnutrition in Copper

Copper is an essential micromineral that acts as a cofactor in many enzymes that function in electron transfer. These enzymes include cytochrome c oxidase (in the electron transport chain), superoxide dismutase (an antioxidant), amine oxidases (for synthesis of neurotransmitter norepinephrine), and lysyl oxidase (involved in collagen crosslinking) (127). Copper is also needed for iron mobilization in the body; thus, copper deficiency manifests as iron deficiency, resulting in low concentrations of RBCs and white blood cells. Patients undergoing malabsorptive bariatric surgery are at risk for impaired copper status due to hypoacidity in the remnant stomach pouch and bypass of the duodenum. Studies have shown that the concentration of blood copper decreases following RYGB (86, 128) and BPD (129, 130) surgery and case reports of severe cases of copper deficiency after these surgeries exist in the literature (131133). Despite the lowering of blood copper concentrations that occurs after malabsorptive surgery, the frequency of copper deficiency after surgery is not clear because copper status is not commonly assessed. The prevalence of copper deficiency ranged from 10 to 15% in cross-sectional studies (128, 134) and 4 to 18% (86, 128, 129) in longitudinal studies. Risk factors for copper deficiency include RYGB and BPD surgery (128, 129) (although there is no data on SG), high zinc supplementation (135), and insufficient copper in micronutrient supplementation (81, 85). The optimum dose of copper supplementation for prevention of copper deficiency is not known, but recent guidelines (35) suggest that multi-vitamin and -mineral supplementation for bariatric surgery patients contain copper at doses close to the RDA (0.9 mg), which is not always the case (81, 85). Another concern is that anemia resulting from copper deficiency is often misdiagnosed as iron or vitamin B-12 deficiency until serious neurological symptoms, such as unsteady gait, extremity numbness, paresthesias, or paralysis, occur that may be irreversible (132). Current methods for assessing copper deficiency rely on blood copper and ceruloplasmin, which are confounded by obesity-induced inflammation (136) and thus may be falsely elevated during deficiency (Table 1). Also, care must be taken to use metal-free blood collection tubes that are commercially available and to avoid environmental contamination when processing (137). Studies in mice with marginal copper deficiency suggest that the cupro-protein, copper chaperone for superoxide dismutase in erythrocytes, may be a more sensitive biomarker than copper and ceruloplasmin, but confirmation is needed in humans (138).

Malnutrition in Zinc

Zinc is a trace mineral used as a co-factor in a diverse list of enzymes, including those involved in protein synthesis, digestion, immunity, and regulation of gene transcription (139). Like other divalent cations (iron, copper, calcium), zinc absorption requires an acidic environment in the stomach and is absorbed in the proximal intestine. Not surprisingly, zinc absorption was demonstrated to have decreased to 42 and 65% of baseline at 6 and 18 mo after gastric by-pass surgery, respectively, in a study using stable isotopes (140). In this study, various markers of zinc status were used, including plasma zinc, hair zinc, erythrocyte membrane alkaline phosphatase, erythrocyte metallothionein, and the exchangeable zinc pool, although the validity of each of these measures has been questioned (141). Nevertheless, using these measures, the prevalence of zinc deficiency increased from preoperative rates of 4–9% to 20–24% at 18 mo following surgery. When serum or plasma zinc was used as an indicator, comparable rates of zinc deficiency were reported by other studies at 24 mo following RYGB (20–35%) and SG (18–34%) surgeries and higher rates were found following BPD (74–91%) (80, 81, 115, 129, 142). Also zinc deficiency was found to persist as late as 60 mo following surgery in SG (12.5%), RYGB (21–33%), and BPD (45%) patients (81, 115, 129). Not all studies have found a decrease in blood concentrations of zinc in patients undergoing malabsorptive bariatric surgery; Rojas et al. (86) showed substantial increases in plasma zinc at 6 mo following RYGB. Assessment of zinc status using systemic zinc concentrations in bariatric surgery patients may be problematic, because serum zinc is decreased in states of obesity-induced inflammation (141, 143). Also, zinc is fairly ubiquitous in the environment and care must be taken not to contaminate samples during assessment; use of metal-free blood collection tubes is advised (137, 144). Moreover, it is important to determine the importance of observations of decreased zinc status following bariatric surgery and the associations with concomitant symptoms of zinc deficiency. Signs and symptoms related to zinc deficiency, including hair loss, poor wound healing, and changes in taste acuity, have been reported in patients after bariatric surgery (145, 146), but these symptoms may not be specific to malnutrition in zinc and may result from deficiencies in other micronutrients, protein, or fatty acids. Like iron, dietary intake of zinc following bariatric surgery can be lower than the recommended amounts due to avoidance of meat and low compliance with adequate supplementation (142, 147). In the study by Rojas et al. (86), extra zinc supplementation have may prevented undernutrition in zinc that is normally observed following RYGB. However, a caveat with zinc supplementation is that excess zinc can lead to the sequestration of copper in gut enterocytes due to zinc-induced upregulation of metallothionein, which binds copper and prevents uptake into the circulation (135). In recognition of this phenomenon, consensus guidelines recommend that patients undergoing zinc supplementation receive 1 mg of copper for each 8–15 mg of zinc provided (35) (Table 1). Additional studies are needed to better describe zinc deficiency following bariatric surgery, including methods for screening that are not confounded by inflammation, the recognition of signs and symptoms, and effective strategies for prevention and treatment.

Concerns in Special Populations

Individuals who are eligible for bariatric surgery include adolescents who are in a life stage of growth and development and there are special concerns regarding the risk of malnutrition in this population. The number of children and teenagers undergoing bariatric surgery is currently at 0.13% of the total number of cases but is expected to increase given trends in pediatric severe obesity and popularity of bariatric surgery (30, 148, 149). Although adolescents experience similar benefits from bariatric surgery related to metabolic health and quality of life (150, 151), data on nutritional variables following surgery are scare (151153). Nutritional outcomes to date are available mostly from patients undergoing AGB or RYGB surgeries, because the SG is emerging (154, 155). The risk of nutritional complications is high because of preexisting malnutrition in vitamin D (156) [and presumably also in iron (74)], the increased nutritional requirements of adolescents (147), and compliance issues that may relate to eating disorders and other psychosocial factors that have been reported in presurgical candidates (157). In teenagers who have RYGB surgery, poor compliance with the postoperative dietary and supplementation regimen has been reported (158). A recent study described the dietary intake and supplement use of adolescents undergoing RYGB and reported low compliance with recommendations for prophylactic calcium supplementation, so intakes of this nutrient were lower than recommended (153). In this same study, participants met or exceeded dietary requirements for intake of folate, iron, and thiamin and vitamins B-12, E, and D, but biochemical indices of these nutrients were not determined. In a separate study, bone mineral content decreased by 7.4% in adolescents 24 mo after RYGB, although Z-scores remained within the normal range. Given the importance of dietary calcium intake during adolescence for bone health (159, 160), longer studies are needed to monitor and improve the adequacy of calcium and vitamin D in this population. Similarly, a comprehensive evaluation of other nutrients, especially iron and zinc, is critically needed in the pediatric population because of the detrimental impact of bariatric surgery on these nutrients in adults (32). Consensus guidelines for nutritional support have been developed by experts in pediatric obesity, surgery, and nutrition, incorporating available data from pediatric and adult literature, and the critical need for additional evidence-based research was acknowledged (155, 161).

The issue of pregnancy following bariatric surgery is two-sided. On the positive side, bariatric surgery is beneficial for improving reproduction function and fertility (162, 163) and also for decreasing obesity-related maternal complications during pregnancy, such as gestational diabetes and preeclampsia as well as macrosomia in the fetus (164, 165). Children born to obese mothers are more susceptible to cardio-metabolic disease in adulthood due to fetal programming (166). Exciting developments in this area from studies of genes and other biomarkers obtained from offspring of women before and after gastric bypass surgery are that children born after surgery showed less predisposition to insulin resistance and other metabolic pathways (167, 168). On the negative side, numerous studies have found adverse fetal outcomes after bariatric surgery, such as shorter gestational age, higher risk of being small for gestational age, and lower birth weight compared with fetal outcomes from women with similar BMI, age, and parity who had not undergone bariatric surgery (164, 169172). Some studies have suggested that RYGB leads to worse outcomes (169) compared with restrictive surgeries, including AGB, but other studies did not find a difference (173175). Adverse fetal outcomes may reflect poor nutritional status of pregnant women who have had bariatric surgery; one study found deficiencies in vitamin B-12, folic acid, iron, and calcium after RYGB (176) and another found higher rates of anemia in bariatric surgery patients compared with nonsurgical controls (164). Another study reported that 85% of women who had undergone bariatric surgery had lower than recommended intake for calcium (177). Thus, although bariatric surgery is promoted as a solution for morbidly obese women who wish to conceive (178), there is a high risk for developmental problems in the fetus related to deficiencies in iron, copper, and zinc and other nutrients with long-term consequences on physical and mental function (179).

In conclusion, the benefits of bariatric surgery are tempered by the high frequency of nutritional deficiencies that occur, some of which are under-recognized and left untreated and lead to devastating consequences to bone health and to the functioning of the immune, nervous, and muscular systems. Bariatric surgery exacerbates preexisting malnutrition in calcium and vitamin D as well as iron due to reduced bioavailability and malabsorption and poor dietary intake and compliance with micronutrient supplementation following surgery. Deficiencies in copper and zinc are difficult to diagnose, because laboratory assessment may be confounded by inflammation and signs and symptoms are shared with deficiencies in other nutrients. These issues are of great importance, especially in special populations such as adolescents as well as pregnant women and their fetuses who may be at risk for developmental problems that affect physical and mental function. Additional research is needed to establish recommendations for prevention and treatment to optimize nutritional outcomes following bariatric surgery.

Acknowledgments

Both authors read and approved the final manuscript.

Footnotes

4

Abbreviations used: AGB, adjustable gastric banding; BPD, biliopancreatic diversion; RYGB, roux-en-y gastric bypass; SG, sleeve gastrectomy; T2DM, type 2 diabetes.

Literature Cited

  • 1.Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36 [DOI] [PubMed] [Google Scholar]
  • 2. Fact sheet: metabolic and bariatric surgery [cited 20 May 2013]. Available from: http://s3.amazonaws.com/publicASMBS/Resources/Fact-Sheets/Metabolic-Bariatric-Surgery-Fact-Sheet-ASMBS2012.pdf.
  • 3.Cohn R, Merrell RC, Koslow A. Gastric stapling for morbid obesity. Am J Surg. 1981;142:67–72 [DOI] [PubMed] [Google Scholar]
  • 4.Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–51 [DOI] [PubMed] [Google Scholar]
  • 5.Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health. 2007;121:492–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond). Epub 2012 Sep 18. [DOI] [PMC free article] [PubMed]
  • 7.Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.NIH Gastrointestinal surgery for severe obesity. NIH consensus development conference. Nutrition. 1996;12:397–4 [PubMed] [Google Scholar]
  • 9.Nguyen NT, Masoomi H, Magno CP, Nguyen X-MT, Laugenour K, Lane J. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011;213:261–6 [DOI] [PubMed] [Google Scholar]
  • 10.Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgery procedures. JAMA. 2005;294:1909–17 [DOI] [PubMed] [Google Scholar]
  • 11.Trus TL, Pope GD, Finlayson SRG. National trends in utilization and outcomes of bariatric surgery. Surg Endosc. 2005;19:616–20 [DOI] [PubMed] [Google Scholar]
  • 12. Fact sheet. Metabolic and bariatric surgery [cited 10 August 2009]. Available from: http://www.asbs.org/Newsite07/media/asmbs_fs_#x003Esurgery.pdf.
  • 13.Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23 [DOI] [PubMed] [Google Scholar]
  • 14.Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17:796–802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009;10:653–62 [DOI] [PubMed] [Google Scholar]
  • 17.Sjöstrom L, Peltonen M, Jacobson P, Sjostrom CD, Karason K, Wedel H, Ahlin S, Anveden A, Bengtsson C, Bergmark G, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65 [DOI] [PubMed] [Google Scholar]
  • 18.Adams TD, Davidson LE, Litwin SE, Kolotkin RL, LaMonte MJ, Pendleton RC, Strong MB, Vinik R, Wanner NA, Hopkins PN, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308:1122–31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Vincent HK, Ben-David K, Conrad BP, Lamb KM, Seay AN, Vincent KR. Rapid changes in gait, musculoskeletal pain, and quality of life after bariatric surgery. Surg Obes Relat Dis. 2012;8:346–54 [DOI] [PubMed] [Google Scholar]
  • 20.Schowalter M, Benecke A, Lager C, Heimbucher J, Bueter M, Thalheimer A, Fein M, Richard M, Faller H. Changes in depression following gastric banding: a 5- to 7-year prospective study. Obes Surg. 2008;18:314–20 [DOI] [PubMed] [Google Scholar]
  • 21.Carlsson LM, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, Jacobson P, Lonroth H, Maglio C, Naslund I, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704 [DOI] [PubMed] [Google Scholar]
  • 22.Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean APH, MacLean LD. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004;240:416–23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sjöstrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, et al. Swedish Obese subjects study: effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52 [DOI] [PubMed] [Google Scholar]
  • 24.Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61 [DOI] [PubMed] [Google Scholar]
  • 25. Medical devices: LAP-BAND adjustable gastric banding system [cited 26 May 2013]. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm248133.htm.
  • 26.Padwal RS, Chang HJ, Klarenbach S, Sharma AM, Majumdar SR. Characteristics of the population eligible for and receiving publicly funded bariatric surgery in Canada. Int J Equity Health. 2012;11:54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Weiner JP, Goodwin SM, Chang H-Y, Bolen SD, Richards TM, Johns RA, Momin SR, Clark JM. Impact of bariatric surgery on health care costs of obese persons. A 6-year follow-up of surgical and comparison cohorts using health plan data. JAMA Surg. 2013;148:555–61 [DOI] [PubMed] [Google Scholar]
  • 28.Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190, 215–357 [DOI] [PubMed] [Google Scholar]
  • 29.Nasraway SA, Jr, Albert M, Donnelly AM, Ruthazer R, Shikora SA, Saltzman E. Morbid obesity is an independent determinant of death among surgical critically ill patients. Crit Care Med. 2006;34:964–70, quiz 971 [DOI] [PubMed] [Google Scholar]
  • 30.DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6:347–55 [DOI] [PubMed] [Google Scholar]
  • 31.Decker GA, Swain JM, Crowell MD, Scolapio JS. Gastrointestinal and nutritional complications after bariatric surgery. Am J Gastroenterol. 2007;102:2571–80 [DOI] [PubMed] [Google Scholar]
  • 32.Saltzman E, Karl JP. Nutritional deficiencies after gastric bypass surgery. Annu Rev Nutr. 2013;33:19.11–.21. [DOI] [PubMed]
  • 33.Lakhani SV, Shah HN, Alexander K, Finelli FC, Kirkpatrick JR, Koch TR. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28:293–8 [DOI] [PubMed] [Google Scholar]
  • 34.Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249–54 [DOI] [PubMed] [Google Scholar]
  • 35.Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery. Obesity (Silver Spring). 2013;21 Suppl 1:S1–27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Clements RH, Katasani VG, Palepu R, Leeth RR, Leath TD, Roy BP, Vickers SM. Incidence of vitamin deficiency after laparoscopic roux-en-y gastric bypass in a university hospital setting. Am Surg. 2006;72:1196–202 [DOI] [PubMed] [Google Scholar]
  • 37.Higa K, Ho T, Tercero F, Yunus T, Boone KB. Laparoscopic roux-en-y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2011;7:516–25 [DOI] [PubMed] [Google Scholar]
  • 38.Gasteyger C, Suter M, Gaillard RC, Giusti V. Nutritional deficiencies after roux-en-y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr. 2008;87:1128–33 [DOI] [PubMed] [Google Scholar]
  • 39.Scarano V, Milone M, Di Minno MN, Panariello G, Bertogliatti S, Terracciano M, Orlando V, Florio C, Leongito M, Lupoli R, et al. Late micronutrient deficiency and neurological dysfunction after laparoscopic sleeve gastrectomy: a case report. Eur J Clin Nutr. 2012;66:645–7 [DOI] [PubMed] [Google Scholar]
  • 40.Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17 Suppl 1:S1–70 [DOI] [PubMed] [Google Scholar]
  • 41.Blackburn GL, Hutter MM, Harvey AM, Apovian CM, Boulton HR, Cummings S, Fallon JA, Greenberg I, Jiser ME, Jones DB, et al. Expert panel on weight loss surgery: executive report update. Obesity (Silver Spring). 2009;17:842–62 [DOI] [PubMed] [Google Scholar]
  • 42.Laferrère B, Teixeira J, McGinty J, Tran H, Egger JR, Colarusso A, Kovack B, Bawa B, Koshy N, Lee H, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479–85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, Camastra S, Bellini R, Berta RD, Ferrannini E. The role of B-cell function and insulin sensitivity in remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96:E1372–9 [DOI] [PubMed] [Google Scholar]
  • 44.Bradley D, Magkos F, Klein S. Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology. 2012;143:897–912 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ, Porter JL, Asplin J, Kuhn JA, Fordtran JS. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–13 [DOI] [PubMed] [Google Scholar]
  • 46.Sarwer DB, Wadden TA, Moore RH, Baker AW, Gibbons LM, Raper SE, Williams NN. Preoperative eating behavior, postoperative dietary adherence, and weight loss after gastric bypass surgery. Surg Obes Relat Dis. 2008;4:640–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Liu X, Lagoy A, Discenza I, Papineau G, Lewis E, Braden G, Romanelli J, Braun B, Silva JE. Metabolic and neuroendocrine responses to roux-en-y gastric bypass. I: Energy balance, metabolic changes, and fat loss. J Clin Endocrinol Metab. 2012;97:E1440–50 [DOI] [PubMed] [Google Scholar]
  • 48.Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJB. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210–5 [DOI] [PubMed] [Google Scholar]
  • 49.Shin AC, Zheng H, Tounsend RL, Sigalet DL, Berthoud H-S. Meal-induced hormone responses in a rat model of roux-en-y gastric bypass surgery. Endocrinology. 2010;151:1588–97 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Carrasco F, Rojas P, Csendes A, Codoceo J, Inostroza J, Basfi-fer K, Papapietro K, Watkins G, Rojas J, Ruz M. Changes in ghrelin concentrations one year after resective and non-resective gastric bypass: associations with weight loss and energy and macronutrient intakes. Nutrition. 2012;28:757–61 [DOI] [PubMed] [Google Scholar]
  • 51.Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci. 1994;39:315–20 [DOI] [PubMed] [Google Scholar]
  • 52.Virji A, Murr MM. Caring for patients after bariatric surgery. Am Fam Physician. 2006;73:1403–8 [PubMed] [Google Scholar]
  • 53.Novais PFS, Junior IR, Shiraga EC, Marques de Oliveira MR. Food aversions in women during the 2 years after roux-en-y gastric bypass. Obes Surg. 2011;21:1921–7 [DOI] [PubMed] [Google Scholar]
  • 54.Schweiger C, Weiss R, Keidar A. Effect of different bariatric operations on food intolerance and quality of eating. Obes Surg. 2010;20:1393–9 [DOI] [PubMed] [Google Scholar]
  • 55.Burton PR, Brown WA. The mechanism of weight loss with laparoscopic adjustable gastric banding: Induction of satiety not restriction. Int J Obes (Lond). 2011;35:S26–30 [DOI] [PubMed] [Google Scholar]
  • 56.Dixon AFR, Dixon JB, O'Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab. 2005;90:813–9 [DOI] [PubMed] [Google Scholar]
  • 57.Biagini J, Karam L. Ten years experience with laparoscopic adjustable gastric banding. Obes Surg. 2008;18:573–7 [DOI] [PubMed] [Google Scholar]
  • 58.Burton PR, Brown W, Laurie C, Lee M, Korin A, Anderson M, Hebbard G, O'Brien PE. Outcomes, satiety, and adverse upper gastrointestinal symptoms following laparoscopic adjustable gastric banding. Obes Surg. 2011;21:574–81 [DOI] [PubMed] [Google Scholar]
  • 59.Ernst B, Thurnheer M, Wilms B, Schultes B. Differential changes in dietary habits after gastric bypass versus gastric banding operations. Obes Surg. 2009;19:274–80 [DOI] [PubMed] [Google Scholar]
  • 60.Solá E, Morillas C, Garzon S, Ferrer JM, Martin J, Hernandez-Mijares A. Rapid onset of Wernicke's encephalopathy following gastric restrictive surgery. Obes Surg. 2003;13:661–2 [DOI] [PubMed] [Google Scholar]
  • 61.Valderas JP, Irribara V, Boza C, de la Cruz R, Liberona Y, Acosta AM, Yolito M, Maiz A. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss. J Clin Endocrinol Metab. 2010;95:1069–75 [DOI] [PubMed] [Google Scholar]
  • 62.Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22:740–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–7 [DOI] [PubMed] [Google Scholar]
  • 64.Shah S, Shah P, Todkar J, Gagner M, Sonar S, Solay S. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6:152–7 [DOI] [PubMed] [Google Scholar]
  • 65.Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, Dolan K, Fielding GA. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8:48–55; discussion 54–45. [DOI] [PubMed]
  • 66.Gluck B, Movitz B, Jansma S, Gluck J, Laskowski K. Laparoscopic sleeve gastrectomy is a safe and effective bariatric procedure for the lower BMI (35.0–43.0 kg/m2) population. Obes Surg. 2011;21:1168–71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Granado-Lorencio F, Simal-Anton A, Salazar-Mosteiro J, Herraro-Barbudo C, Donaso-Navarro E, Blanco-Navarro I, Perez-Sacristan B. Time course changes in bone turnover markers and fat soluble vitamins after obesity surgery. Obes Surg. 2010;20:1524–9 [DOI] [PubMed] [Google Scholar]
  • 68.Brolin RE, Leung BS. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg. 1999;9:150–4 [DOI] [PubMed] [Google Scholar]
  • 69.Aasheim ET, Bjorkman S, Sovik TT, Engstrom M, Hanvold SE, Mala T, Olbers T, Bohmer T. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr. 2009;90:15–22 [DOI] [PubMed] [Google Scholar]
  • 70.Kumar R, Lieske JC, Collazo-Clavell ML, Sarr MG, Olson ER, Vrtiska TJ, Bergstralh EJ, Li X. Fat malabsorption and increased oxalate absorption are common after roux-en-y gastric bypass surgery. Surgery. 2011;149:654–61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. MedGenMed. 2006;8:59. [PMC free article] [PubMed] [Google Scholar]
  • 72.Pramyothin P, Biancuzzo RM, Lu Z, Hess DT, Apovian CM, Holick MF. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-y gastric bypass. Obesity (Silver Spring). 2011;19:2228–34 [DOI] [PubMed] [Google Scholar]
  • 73.Wortsman J, Matsuoka LY, Chen TC, Zu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690–3 [DOI] [PubMed] [Google Scholar]
  • 74.Cepeda-Lopez AC, Aeberli I, Zimmermann MB. Does obesity increase the risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res. 2010;80:263–70 [DOI] [PubMed] [Google Scholar]
  • 75.Marreiro DN, Fisberg M, Cozzolino SM. Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res. 2004;100:137–49 [DOI] [PubMed] [Google Scholar]
  • 76.Institute of Medicine Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press; 2010.
  • 77.Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition. 2009;25:1150–6 [DOI] [PubMed] [Google Scholar]
  • 78.Damms-Machado A, Friedrich A, Kramer KM, Stingel K, Meile T, Kuper MA, Konigrainer A, Bischoff SC. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic gastrectomy. Obes Surg. 2012;22:881–9 [DOI] [PubMed] [Google Scholar]
  • 79.Moizé V, Deulofeu R, Torres F, Martinez de Osaba J, Vidal J. Nutritional intake and prevalence of nutritional deficiencies prior to surgery in a Spanish morbidly obese population. Obes Surg. 2011;21:1382–8 [DOI] [PubMed] [Google Scholar]
  • 80.Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic roux-y-gastric bypass (LRYGB): a prospective study. Obes Surg. 2010;20:447–53 [DOI] [PubMed] [Google Scholar]
  • 81.Moizé V, Andreu A, Flores L, Torres F, Ibarzabal A, Delgado S, Lacy A, Rodriguez L, Vidal J. Long-term dietary intake and nutritional deficiencies following sleeve gastrectomy or Roux-En-Y gastric bypass in a Mediterranean population. J Acad Nutr Diet. 2013;113:400–10 [DOI] [PubMed] [Google Scholar]
  • 82.Jin J, Stellato TA, Hallowell PT, Schuster M, Graf K, Wilhelm S. Utilization of preoperative patient factors to predict postoperative vitamin D deficiency for patients undergoing gastric bypass. J Gastrointest Surg. 2009;13:1052–7 [DOI] [PubMed] [Google Scholar]
  • 83.Gemmel K, Santry H, Prachand V, Alverdy J. Vitamin D deficiency in preoperative bariatric surgery patients. Surg Obes Relat Dis. 2009;5:54–9 [DOI] [PubMed] [Google Scholar]
  • 84.Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Preoperative nutritional deficiencies in severely obese bariatric candidates are not linked to gastric Helicobacter pylori infection. Obes Surg. 2013;23:698–702 [DOI] [PubMed] [Google Scholar]
  • 85.Coupaye M, Puchaux K, Bogard C, Msika S, Jouet P, Clerici C, Larger E, Ledoux S. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg. 2009;19:56–65 [DOI] [PubMed] [Google Scholar]
  • 86.Rojas P, Carrasco F, Codoceo J, Inostroza J, Basfi-fer K, Papapietro K, Csendes A, Rojas J, Pizarro F, Olivares M, et al. Trace element status and inflammation parameters after 6 months of roux-en-y gastric bypass. Obes Surg. 2011;21:561–8 [DOI] [PubMed] [Google Scholar]
  • 87.Blume CA, Boni CC, Casagrande DS, Rizzolli J, Padoin AV, Mottin CC. Nutritional profile of patients before and after roux-en-y gastric bypass: 3 year follow-up. Obes Surg. 2012;22:1676–85 [DOI] [PubMed] [Google Scholar]
  • 88.Ernst B, Thurnheer M, Schmid SM, Schultes B. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg. 2009;19:66–73 [DOI] [PubMed] [Google Scholar]
  • 89.Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18:648–51 [DOI] [PubMed] [Google Scholar]
  • 90.Toussi R, Fujioka K, Coleman KJ. Pre- and postsurgery behavioral compliance, patient health, and post-bariatric surgical weight loss. Obesity (Silver Spring). 2009. 17:996–1002. [DOI] [PubMed]
  • 91.Ahmad DS. Malnutrition secondary to non-compliance with vitamin and mineral supplements after gastric bypass surgery: what can we do about it? Am J Case Rep. 2012;13:209–13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Wood RJ. Calcium and phosphorus. In: Stipanuk MH, editor. Biochemical and physiological aspects of human nutrition. Philadelphia: Elsevier; 2000. p. 643–70.
  • 93.Weaver CM, Fleet JC. Vitamin D requirements: current and future. Am J Clin Nutr. 2004;80:S1735–9 [DOI] [PubMed] [Google Scholar]
  • 94.Fleet JC. Molecular mechanims for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci. 2010;47:181–95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81 [DOI] [PubMed] [Google Scholar]
  • 96.US Preventative Services Task Force Screening for osteoporosis: U.S. preventative services task force recommendation statement. Ann Intern Med. 2011;154:356–64 [DOI] [PubMed] [Google Scholar]
  • 97.Hill KM, Braun MM, Egan KA, Martin BR, McCabe LD, Peacock M, McCabe GP, Weaver CM. Obesity augments calcium-induced increases in skeletal calcium retention in adolescents. J Clin Endocrinol Metab. 2011;96:2171–7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Schwartz AV, Johnson KC, Kahn SE, Shepherd JA, Nevitt MC, Peters AL, Walkup MP, Hodges A, Williams CC, Bray GA. Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res. 2012;27:619–27 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Fogelholm GM, Sievanen HT, Kukkonen-Harjula TK, Pasanen ME. Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women. Osteoporosis Int. 2001;12:199–206 [DOI] [PubMed] [Google Scholar]
  • 100.Riedt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring). 2006;14:1940–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Lin E, Armstrong-Moore D, Liang Z, Sweeney JF, Torres WE, Ziegler TR, Tangpricha V, Gletsu-Miller N. Contribution of adipose tissue to plasma 25-hydroxyvitamin d concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring). 2011;19:588–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Sánchez-Hernández J, Ybarra J, Gich I, de Leiva A, Ruis X, Rodriguez-Espinosa J, Perez A. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg. 2005;15:1389–95 [DOI] [PubMed] [Google Scholar]
  • 103.Elliot K. Nutritional considerations after bariatric surgery. Crit Care Nurs Q. 2003;26:133–8 [DOI] [PubMed] [Google Scholar]
  • 104.Bloomberg RD, Fleishman A, Nalle JE, Herron DM, Kini S. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg. 2005;15:145–54 [DOI] [PubMed] [Google Scholar]
  • 105.Goode LR, Brolin RE, Chowdhury HA, Shapses SA. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–7 [DOI] [PubMed] [Google Scholar]
  • 106.Stein EM, Carrelli A, Young P, Bucovsky M, Zhang C, Schrope B, Bessler M, Zhou B, Wang J, Gou XE, et al. Bariatric surgery results in cortical bone loss. J Clin Endocrinol Metab. 2013;98:541–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Casagrande DS, Repetto G, Mottin CC, Shah J, Pietrobon R, Worni M, Schaan BD. Changes in bone mineral density in women following 1-year gastric bypass surgery. Obes Surg. 2012;22:1287–92 [DOI] [PubMed] [Google Scholar]
  • 108.Fleischer J, Stein EM, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L, McMahon DJ, Silverberg SJ. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab. 2008;93:3735–40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Vilarrasa N, San Jose P, Garcia I, Gomez-Vaquero C, Miras PM, de Gordejuela AG, Masdevall C, Pujol J, Soler J, Gomez JM. Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up. Obes Surg. 2011;21:465–72 [DOI] [PubMed] [Google Scholar]
  • 110.DiGiorgi M, Daud S, Inabnet WB, Schrope B, Urban-Skuro M, Restuccia N, Bessler M. Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable banding. Obes Surg. 2008;18:1144–8 [DOI] [PubMed] [Google Scholar]
  • 111.Mahdy T, Atia S, Farid M, Adulatif A. Effect of roux-en-y gastric bypass on bone metabolism in patients with morbid obesity: Mansoura experiences. Obes Surg. 2008;18:1526–31 [DOI] [PubMed] [Google Scholar]
  • 112.McClung JP, Marchitelli LJ, Friedl KE, Young AJ. Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr. 2006;25:64–9 [DOI] [PubMed] [Google Scholar]
  • 113.Gudzune KA, Huizinga MM, Chang HY, Asamoah V, Gadgil M, Clark JM. Screening and diagnosis of micronutrient deficiencies before and after bariatric surgery. Obes Surg. Epub 2013 Mar 21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Vargas-Ruiz AG, Hernandez-Rivera G, Herrera MF. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2008;18:288–93 [DOI] [PubMed] [Google Scholar]
  • 115.Thurnheer M, Bisang P, Ernst B, Schultes B. A novel distal very long roux-en-y gastric bypass (DVLRYGB) as a primary bariatric procedure: complication rates, weight loss, and nutritional/metabolic changes in the first 355 patients. Obes Surg. 2012;22:1427–36 [DOI] [PubMed] [Google Scholar]
  • 116.Naghshineh N, Coon DO, McTigue KM, Courcoulas A, Fernstrom M, Rubin JP. Nutritional assessment of bariatric surgery patients presenting for plastic surgery: a prospective analysis. Plast Reconstr Surg. 2010;126:602–10 [DOI] [PubMed] [Google Scholar]
  • 117.Kushner RF, Gleason B, Shanta-Retelny V. Reemergence of pica following gastric bypass surgery for obesity: a new presentation of an old problem. J Am Diet Assoc. 2004;104:1393–7 [DOI] [PubMed] [Google Scholar]
  • 118.Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Basfi-fer K, Valencia A, Csendes A, Papapietro K, Pizarro F, et al. Heme- and nonheme-iron absorption and iron status 12 mo after sleeve gastrectomy and roux-en-y gastric bypass in morbidly obese women. Am J Clin Nutr. 2012;96:810–7 [DOI] [PubMed] [Google Scholar]
  • 119.Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Rebolledo A, Basfi-fer K, Csendes A, Papapietro K, Pizarro F, et al. Iron absorption and iron status are reduced after Roux-en-Y gastric bypass. Am J Clin Nutr. 2009;90:527–32 [DOI] [PubMed] [Google Scholar]
  • 120.Olivares M, Pizarro F, Ruz M, de Romana DL. Acute inhibition of iron bioavailability by zinc: studies in humans. Biometals. 2012;25:657–64 [DOI] [PubMed] [Google Scholar]
  • 121.Solomons NW. Competitive interaction of iron and zinc in the diet: Consequences for human nutrition. J Nutr. 1986;116:927–35 [DOI] [PubMed] [Google Scholar]
  • 122.Björn-Rasmussen E. Hallberg L. Iron absorption from maize. Effect of ascorbic acid on iron absorption from maize supplemented with ferrous sulphate. Nutr Metab. 1974;16:94–100 [PubMed] [Google Scholar]
  • 123.Failla ML, Johnson MA, Prohaska JR. Copper. In: Bowman BA, Russell RM, editors. Present knowledge in nutrition. 8th ed. Washington, DC: ILSI Press; 2001: 373–83.
  • 124.Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21:195–9 [DOI] [PubMed] [Google Scholar]
  • 125.Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007;370:511–20 [DOI] [PubMed] [Google Scholar]
  • 126.Malone M, Barish C, He A, Bregman D. Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for treatment of iron-deficiency anemia in bariatric and gastric surgery patients. Obes Surg. Epub 2013 Apr 4. [DOI] [PubMed]
  • 127.Mason KE. A conspectus of research on copper metabolism and requirements of man. J Nutr. 1979;109:1979–2066 [DOI] [PubMed] [Google Scholar]
  • 128.Gletsu-Miller N, Broderius M, Frediani JK, Zhao VM, Griffith DP, Davis SS, Jr, Sweeney JF, Lin E, Prohaska JR, Ziegler TR. Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int J Obes (Lond). 2012;36:328–35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Balsa JA, Botella-Carretero JI, Gomez-Martin JM, Peromingo R, Arrieta F, Santiuste C, Zamarron I, Vazquez C. Copper and zinc serum levels after derivative bariatric surgery: Differences between roux-en-y gastric bypass and biliopancreatic diversion. Obes Surg. 2011;21:744–50 [DOI] [PubMed] [Google Scholar]
  • 130.Atkinson RL, Dahms WT, Bray GA, Jacob R, Sandstead HH. Plasma zinc and copper in obesity and after intestinal bypass. Ann Intern Med. 1978;89:491–3 [DOI] [PubMed] [Google Scholar]
  • 131.O'Donnell KB, Simmons M. Early-onset copper deficiency following roux-en-y gastric bypass. Nutr Clin Pract. 2011;26:66–9 [DOI] [PubMed] [Google Scholar]
  • 132.Griffith DP, Liff DA, Ziegler TR, Esper GJ, Winton EF. Acquired copper deficiency: a potential serious and preventable complication following gastric bypass surgery. Obesity (Silver Spring). 2009;17:827–31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Prodan CI, Bottomley SS, Holland NR, Lind SE. Relapsing hypocupraemic myelopathy requiring high-dose oral copper replacement. J Neurol Neurosurg Psychiatry. 2006;77:1092–3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Ernst B, Thurnheer M, Schultes B. Copper deficiency after gastric bypass surgery. Obesity (Silver Spring). 2009;17:1980–1 [DOI] [PubMed] [Google Scholar]
  • 135.Hoffman HNI, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology. 1988;94:508–12 [DOI] [PubMed] [Google Scholar]
  • 136.Prohaska JR, Wittmers LE, Haller EW. Influence of genetic obesity, food intake and adrenalectomy in mice on selected trace element: dependent protective enzymes. J Nutr. 1988;118:739–46 [DOI] [PubMed] [Google Scholar]
  • 137.Moyer TP, Mussmann GV, Nixon DE. Blood-collection device for trace and ultra-trace metal specimens evaluated. Clin Chem. 1991;37:709–14 [PubMed] [Google Scholar]
  • 138.Lassi KC, Prohaska JR. Erythrocyte copper chaperone for superoxide dismutase is increased following marginal copper deficiency in adult and postweanling mice. J Nutr. 2012;142:292–7 [DOI] [PubMed] [Google Scholar]
  • 139.Cousins RJ, Blanchard RK, Moore JB, Cui L, Green CL, Liuzzi JP, Cao J, Bobo JA. Regulation of zinc metabolism and genomic outcomes. J Nutr. 2003;133:S1521–6 [DOI] [PubMed] [Google Scholar]
  • 140.Ruz M, Carrasco F, Rojas P, Codoceo J, Inostroza J, Basfi-fer K, Csendes A, Papapietro K, Pizarro F, Olivares M, et al. Zinc absorption and zinc status are reduced after roux-en-y gastric bypass: a randomized study using 2 supplements. Am J Clin Nutr. 2011;94:1004–11 [DOI] [PubMed] [Google Scholar]
  • 141.Ruz M, Cavan KR, Bettger WJ, Thompson L, Berry M, Gibson RS. Development of a dietary model for the study of mild zinc deficiency in humans and evaluation of some biochemical and functional indices of zinc status. Am J Clin Nutr. 1991;53:1295–303 [DOI] [PubMed] [Google Scholar]
  • 142.Sallé A, Demarsy D, Poireir AL, Lelievre B, Guilloteau G, Becouarn G, Rohmer V. Zinc deficiency: a frequent and underestimated complication after bariatric surgery. Obes Surg. 2010;20:1660–70 [DOI] [PubMed] [Google Scholar]
  • 143.Di Martino G, Matera MG, De Martino B, Vacca C, Di Martino S, Rossi F. Relationship between zinc and obesity. J Med. 1993;24:177–83 [PubMed] [Google Scholar]
  • 144.Williams DM. Trace metal determinations in blood obtained in evacuated collection tubes. Clin Chim Acta. 1979;99:23–9 [DOI] [PubMed] [Google Scholar]
  • 145.Pech N, Meyer F, Lippert H, Manger T, Stroh C. Complications, reoperations, and nutrient deficiencies two years after sleeve gastrectomy. BMC Surg. 2012;12:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.le Roux CW, Bueter M, Theis N, Werling M, Ashrafian H, Lowenstein C, Athanasiou T, Bloom SR, Spector AC, Olbers T, et al. Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol. 2011;301:R1057–66 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.U.S. Department of Health and Human Services and U.S. Department of Agriculture. Dietary guidelines for Americans, 2010. USDA/HHS ed. Washington, DC: U.S. Government Printing Office; 2010. [DOI] [PMC free article] [PubMed]
  • 148.Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA. 2010;303:242–9 [DOI] [PubMed] [Google Scholar]
  • 149.Tsai WS, Inge TH, Burd RS. Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med. 2007;161:217–21 [DOI] [PubMed] [Google Scholar]
  • 150.Zeller MH, Reiter-Purtill J, Ratcliffe MB, Inge TH. Two-year trends in psychosocial functioning after adolescent roux-en-y gastric bypass. Surg Obes Relat Dis. 2011;7:727–32 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Nadler EP, Youn HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg. 2008;43:141–6 [DOI] [PubMed] [Google Scholar]
  • 152.Kaulfers A-MD, Bean JA, Inge TH, Dolan LM, Kalkwarf HJ. Bone loss in adolescents after bariatric surgery. Pediatrics. 2011;127:e956–61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153.Jeffreys RM, Hrovat K, Woo JG, Schmidt M, Inge TH, Xanthakos SA. Dietary assessment of adolescents undergoing laparoscopic roux-en-y gastric bypass surgery: macro- and micronutrient, fiber and supplement intake. Surg Obes Relat Dis. 2012;8:331–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154.Jen HC, Rickard DG, Shew SB, Maggard MA, Slusser WM, Dutson EP, DeUgarte DA. Trends and outcomes of adolescent bariatric surgery in California, 2005–2007. Pediatrics. 2010;126:e746–53 [DOI] [PubMed] [Google Scholar]
  • 155.Michalsky M, Reichard K, Inge TH, Pratt J, Lenders C. ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis. 2012;8:1–7 [DOI] [PubMed] [Google Scholar]
  • 156.Censani M, Stein EM, Shane E, Oberfield SE, McMahon DJ, Lerner S, Fennoy I. Vitamin D deficiency is prevalent in morbidly obese adolescents prior to bariatric surgery. ISRN Obes. Epub 2013, June 1. [DOI] [PMC free article] [PubMed]
  • 157.Sysko R, Zakarin EB, Devlin MJ, Bush J, Walsh BT. A latent class analysis of psychiatric symptoms among 125 adolescents in a bariatric surgery program. Int J Pediatr Obes. 2011;6:289–97 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Rand CS, Macgregor AM. Adolescents having obesity surgery: a 6-year follow-up. South Med J. 1994;87:1208–13 [DOI] [PubMed] [Google Scholar]
  • 159.Jackman LA, Millane SS, Martin BR, Wood OB, McCabe GP, Peacock M, Weaver CM. Calcium retention in relation to calcium intake and postmenarcheal age in adolescent females. Am J Clin Nutr. 1997;66:327–33 [DOI] [PubMed] [Google Scholar]
  • 160.Hill KM, Braun M, Kern M, Martin BR, Navalta JW, Sedlock DA, McCabe L, McCabe GP, Peacock M, Weaver CM. Predictors of calcium retention in adolescent boys. J Clin Endocrinol Metab. 2008;93:4743–8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161.Fullmer MA, Abrams SH, Hrovat K, Mooney L, Scheimann AO, Hillman JB, Suskind DL. Nutritional strategy for adolescents undergoing bariatric surgery: Report of a working group of the Nutrition Committee of NASPGHAN/NACHRI. J Pediatr Gastroenterol Nutr. 2012;54:125–35 [DOI] [PubMed] [Google Scholar]
  • 162.Jamal M, Gunay Y, Capper A, Eid A, Heitshusen D, Samuel I. Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis. Surg Obes Relat Dis. 2012;8:440–4 [DOI] [PubMed] [Google Scholar]
  • 163.Legro RS, Dodson WC, Gnatuk CL, Estes SJ, Kunselman AR, Meadows JW, Kesner JS, Krieg EFJ, Rogers AM, Haluck RS, et al. Effects of gastric bypass surgery on reproductive function. J Clin Endocrinol Metab. 2012;97:4540–48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Belogolovkin V, Salihu HM, Weldeselasse H, Biroscak BJ, August EM, Mbah AK, Alio AP. Impact of prior bariatric surgery on maternal and fetal outcomes among obese and non-obese mothers. Arch Gynecol Obstet. 2012;285:1211–8 [DOI] [PubMed] [Google Scholar]
  • 165.Lapolla A, Marangon M, Dalfra MG, Segato G, De Luca M, Fedele D, Favretti F, Enzi G, Busetto L. Pregnancy outcome in morbidly obese women before and after laparoscopic gastric banding. Obes Surg. 2010;20:1251–7 [DOI] [PubMed] [Google Scholar]
  • 166.Hochner H, Friedlander Y, Calderon-Margalit R, Meiner V, Sagy Y, Avgil-Tsadok M, Burger A, Savitsky B, Siscovick DS, Manor O. Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study. Circulation. 2012;125:1381–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Guénard F, Deshaies Y, Cianflone K, Kral JG, Marceau P, Vohl MC. Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci U S A. 2013;110:11439–44 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168.Smith J, Cianflone K, Biron S, Hould FS, Lebel S, Marceau S, Lescelleur O, Biertho L, Simard S, Kral JG, et al. Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity. J Clin Endocrinol Metab. 2009;94:4275–83 [DOI] [PubMed] [Google Scholar]
  • 169.Kjaer MM, Lauenborg J, Breum BM, Nilas L. The risk of adverse pregnancy outcome after bariatric surgery; a nationwide register-based matched cohort study. Am J Obstet Gynecol. 2013;208:464.e1–5. [DOI] [PubMed]
  • 170.Lesko J, Peaceman A. Pregnancy outcomes in women after bariatric surgery compared with obese and morbidly obese controls. Obstet Gynecol. 2012;119:547–54 [DOI] [PubMed] [Google Scholar]
  • 171.Josefsson A, Blomberg M, Bladh M, Fredricksen SG, Sydsjo G. Bariatric surgery in a national cohort of women: sociodemographics and obstetric outcomes. Am J Obstet Gynecol. 2011;205:e1–8 [DOI] [PubMed] [Google Scholar]
  • 172.Santulli P, Mandelbrot L, Facchiano E, Dussaux C, Ceccaldi PF, Ledoux S, Msika S. Obstetrical and neonatal outcomes of pregnancies following gastric bypass surgery: a retrospective cohort study in a French referral centre. Obes Surg. 2010;20:1501–8 [DOI] [PubMed] [Google Scholar]
  • 173.Ducarme G, Parisio L, Santulli P, Carbillon L, Mandelbrot L, Luton D. Neonatal outcomes in pregnancies after bariatric surgery: a retrospective multi-centric cohort study in three French referral centers. J Matern Fetal Neonatal Med. 2013;26:275–8 [DOI] [PubMed] [Google Scholar]
  • 174.Facchiano E, Iannelli A, Santulli P, Mandelbrot L, Msika S. Pregnancy after laparoscopic bariatric surgery: comparative study of adjustable gastric banding and Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2012;8:429–33 [DOI] [PubMed] [Google Scholar]
  • 175.Sheiner E, Balaban E, Dreiher J, Levi I, Levy A. Pregnancy outcome in patients following different types of bariatric surgeries. Obes Surg. 2009;19:1286–92 [DOI] [PubMed] [Google Scholar]
  • 176.Bebber FE, Rizzolli J, Casagrande DS, Rodrigues MT, Padoin AV, Mottin CC, Repetto G. Pregnancy after bariatric surgery: 39 pregnancies follow-up in a multidisciplinary team. Obes Surg. 2011;21:1546–51 [DOI] [PubMed] [Google Scholar]
  • 177.Guelinckx I, Devlieger R, Donceel P, Bel S, Pauwels S, Bogaerts A, Thijs I, Schurmans K, Deschilder P, Vansant G. Lifestyle after bariatric surgery: a multicenter, prospective cohort study in pregnant women. Obes Surg. 2012;22:1456–64 [DOI] [PubMed] [Google Scholar]
  • 178. New hope for women with morbid obesity trying to get pregnant [cited 3 June 2013]. Available from: http://asmbs.org/2012/06/reversing-infertility/
  • 179.Martorell R, Zongrone A. Intergenerational influences on child growth and undernutrition. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:302–14 [DOI] [PubMed] [Google Scholar]

Articles from Advances in Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES